(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 8.98%337.21M | 17.14%641.77M | 19.63%309.43M | 14.69%547.87M | --258.65M | 10.94%477.7M | --430.59M |
Operating income | 8.98%337.21M | 17.14%641.77M | 19.63%309.43M | 14.69%547.87M | 258.65M | 10.94%477.7M | 430.59M |
Cost of sales | -7.69%-189.56M | -11.23%-359.08M | -15.50%-176.03M | -9.28%-322.83M | ---152.4M | -12.91%-295.4M | ---261.63M |
Operating expenses | -7.69%-189.56M | -11.23%-359.08M | -15.50%-176.03M | -9.28%-322.83M | -152.4M | -12.91%-295.4M | -261.63M |
Gross profit | 10.68%147.65M | 25.62%282.69M | 25.56%133.4M | 23.45%225.04M | 106.25M | 7.89%182.3M | 168.96M |
Selling expenses | -11.75%-3.91M | 14.88%-6.07M | -30.78%-3.5M | -16.25%-7.13M | ---2.67M | -20.93%-6.13M | ---5.07M |
Administrative expenses | -2.93%-65.26M | -86.35%-143.46M | -88.65%-63.4M | -8.27%-76.98M | ---33.61M | -66.99%-71.1M | ---42.58M |
Research and development expenses | -28.75%-8.65M | -49.64%-13.51M | -53.48%-6.72M | 4.10%-9.03M | ---4.38M | 8.58%-9.41M | ---10.3M |
Impairment and provision | 86.25%-502K | 60.74%-1M | -81.50%-3.65M | -2,422.73%-2.56M | ---2.01M | 114.29%110K | ---770K |
-Other impairment is provision | 86.25%-502K | 60.74%-1M | -81.50%-3.65M | -2,422.73%-2.56M | ---2.01M | 114.29%110K | ---770K |
Special items of operating profit | -81.29%154K | -3.35%1.5M | 51.01%823K | 251.93%1.55M | --545K | -20.40%441K | --554K |
Operating profit | 21.99%69.48M | -8.21%120.15M | -11.17%56.96M | 36.07%130.9M | 64.12M | -13.17%96.2M | 110.8M |
Financing income | 357.27%3.82M | ---- | ---1.49M | ---- | ---- | ---- | ---- |
Financing cost | ---- | 30.95%-2.26M | ---- | -7.17%-3.27M | ---1.24M | -216.80%-3.05M | ---964K |
Earning before tax | 32.15%73.31M | -7.63%117.89M | -11.79%55.47M | 37.01%127.63M | 62.88M | -15.19%93.15M | 109.83M |
Tax | 23.17%-15.51M | 50.91%-15.57M | -36.39%-20.18M | -236.74%-31.71M | ---14.8M | -320.51%-9.42M | --4.27M |
After-tax profit from continuing operations | 63.79%57.8M | 6.68%102.32M | -26.61%35.29M | 14.55%95.91M | 48.09M | -26.62%83.73M | 114.11M |
Earning after tax | 63.79%57.8M | 6.68%102.32M | -26.61%35.29M | 14.55%95.91M | 48.09M | -26.62%83.73M | 114.11M |
Minority profit | ---- | ---- | ---- | --35K | --35K | ---- | ---- |
Profit attributable to shareholders | 63.79%57.8M | 6.72%102.32M | -26.56%35.29M | 14.51%95.88M | 48.05M | -26.62%83.73M | 114.11M |
Basic earnings per share | 23.71%0.2891 | 5.79%0.6762 | -26.97%0.2337 | 14.14%0.6392 | 0.32 | -26.32%0.56 | 0.76 |
Diluted earnings per share | 22.76%0.2869 | 5.62%0.6751 | -26.97%0.2337 | 14.14%0.6392 | 0.32 | -26.32%0.56 | 0.76 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data